MIRA INFORM REPORT

 

 

Report Date :           

10.03.2011

 

IDENTIFICATION DETAILS

 

Name :

RTM PHARMACEUTICALS LLC

 

 

Registered Office :

108 West 13th Street - Wilmington - New Castle - DE

 

 

Country :

United States 

 

 

Date of Incorporation :

02.11.2007

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Pharmaceutical Company

 

 

RATING & COMMENTS

 

MIRA’s Rating :

C

 

RATING

STATUS

PROPOSED CREDIT LINE

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

 

Status :

Undetermined

 

 

Payment Behaviour :

-----

 

 

Litigation :

-----

 


 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2010

 

Country Name

Previous Rating

                   (30.09.2010)                  

Current Rating

(31.12.2010)

United States 

a1

a1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


GEOPOLITICS - UNITED STATES

 

POLITICAL DATA

ECONOMIC DATA

Form of Government: Federal


Economic Risk: Nil

Currency: USD

Branch Situation: Unknown

 

 

IDENTIFICATION

 

Ordered as:

RTM Pharmaceuticals LLC

Address in the order:

40674 Pimecie Tearace Eden NY 14057

USA

 

 

Legal Name:

RTM Pharmaceuticals LLC

 

 

Legal Address

108 West 13th Street - Wilmington - New Castle - DE - USA (Registered agent address)

Operative Address

40674 Pimecie Tearace Eden NY 14057 - USA (headquarters - not verified)

 

Telephone:

(724) 302-0172

ID :

4451277

Fax:

(724) 302-0172

Legal Form:

Limited Liability Company

Email:

NA

Registered in:

Delaware

Website:

http://www.rtmpharma.com/

Date Created:

NA

Manager:

NA

Date Incorporated:

November 2nd. 2007

Staff:

NA

Stock:

NA

 

 

Value:

NA

Activity:

Pharmaceutical company

 

 

BUSINESS

 

PRINCIPAL ACTIVITY

 

Dear client

 

Your order was on:

RTM Pharmaceuticals LLC

40674 Pimecie Tearace Eden NY 14057

 

The company is registered in the Secretary of State of New York and incorporated in the Secretary of State of Delaware (due to tax purposes).

 

It is registered under the number 4451277 in 11/02/2007. It appears as active.

 

Secretary of State of New York

 

Selected Entity Name: RTM PHARMACEUTICALS, L.L.C.

Current Entity Name: RTM PHARMACEUTICALS, L.L.C.

Initial DOS Filing Date: NOVEMBER 19, 2010

County: ERIE

Jurisdiction: DELAWARE

Entity Type: FOREIGN LIMITED LIABILITY COMPANY

Current Entity Status: ACTIVE

 

Secretary of State of Delaware

 

File Number: 4451277

Incorporation Date / Formation Date:        11/02/2007

Entity Name: RTM PHARMACEUTICALS, L.L.C.

Entity Kind: LIMITED LIABILITY COMPANY

Entity Type: GENERAL

Residency: DOMESTIC

State: DE

REGISTERED AGENT INFORMATION

Name: BUSINESS FILINGS INCORPORATED

Address: 108 WEST 13TH STREET

City: WILMINGTON

County: NEW CASTLE

State: DE

 

Dear client,

 

The telephone number you provided us, is that of the company with a same name located in Pennsylvania. We have called it many times, but we were unable to speak with anybody in order to find what the relationship of the company in New York is (if there is a connection between them).

 

We have also left many messages, which kept unanswered.

 

We have received no answer when calling this telephone number: (001) 724-302-0172

 

We could not find any number for the company in New York.

 

We were able to find that RTM Pharmaceuticals, LLC. would be a privately held pharmaceutical company located in Eden, New York. RTM Pharmaceuticals would focus on partnerships with developers of specialty generic products, marketers and distributors and active pharmaceutical ingredient manufacturers.  

 

We need a telephone number for the company in New York.

 

 

 

Rating

 

The company is in Good Standing. This means that all local and federal taxes were paid on due date.

 Final Opinion

 

Despite our long searches, we were unable to find a telephone number for the company located in New York.

 

We called the company located in Pennsylvania, but nobody would answer to our calls, so we were unable to check what the relationship of the company in New York is (if there is a connection between them). We have also left many messages, which kept unanswered.

 

We need a telephone number for the company located in New York, since we have the telephone number for the company in Pennsylvania, but we were unable to speak with anybody.

 

 

SUMMARY

 


FINANCIAL SUMMARY


DEBT COLLECTIONS AND PAYMENTS

Profitability

N.A.

Public

NO

Indebtedness

N.A.

Payments

N.A.

Cash

N.A.

 

 




 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.02

UK Pound

1

Rs.72.70

Euro

1

Rs.62.54

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.